CD68 Monoclonal Antibody

文獻引用 (1) 說明書

中文名稱：

CD68鼠單克隆抗體
貨號：

CSB-MA000323
規(guī)格：

￥1090
圖片：
IHC staining of human tonsil tissue, diluted at 1:200.
其他：

產品詳情
產品評價
引用文獻
相關產品
靶點詳情

產品詳情

產品描述：

本產品為CD68單克隆抗體（CUSABIO貨號：CSB-MA000323），特異性識別人類、小鼠及大鼠CD68蛋白，該靶標是巨噬細胞和單核細胞特異性表面標志物，在免疫系統(tǒng)調控、炎癥反應及組織修復過程中發(fā)揮關鍵作用。該抗體采用雜交瘤技術制備，具有高批次穩(wěn)定性和優(yōu)異抗原結合能力，經(jīng)嚴格驗證適用于酶聯(lián)免疫吸附實驗（ELISA）和免疫組織化學（IHC）檢測。在腫瘤微環(huán)境分析、動脈粥樣硬化病理研究及神經(jīng)退行性疾病模型中，本抗體可精準定位組織樣本中的巨噬細胞分布，輔助研究者解析免疫細胞浸潤特征；在體外實驗中可配合ELISA技術定量檢測CD68表達水平，為炎癥性疾病機制研究提供可靠工具。該產品經(jīng)過交叉反應性驗證，確保與人源、鼠源及大鼠源樣本兼容，適用于多物種實驗體系的免疫組化切片染色及蛋白定量檢測，為免疫學、病理學及細胞生物學領域的CD68靶點研究提供優(yōu)質科研試劑。
Uniprot No.：

P34810
基因名：

CD68
別名：

CD68; Macrosialin; Gp110; CD antigen CD68
宿主：

Mouse
反應種屬：

Human,Mouse,Rat
免疫原：

Synthetic Peptide
免疫原種屬：

H, M, R
標記方式：

Non-conjugated
抗體亞型：

IgG
克隆號：

22D12
濃度：

It differs from different batches. Please contact us to confirm it.
保存緩沖液：

PBS, pH 7.4, containing 0.5%BSA, 0.02% sodium azide as Preservative and 50% Glycerol.
產品提供形式：

Liquid
應用范圍：

ELISA,IHC

推薦稀釋比：

Application	Recommended Dilution
IHC	1:100-1:200

Protocols：

ELISA Protocol
Immunohistochemistry (IHC) Protocol
儲存條件：

Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
貨期：

Basically, we can dispatch the products out in 1-3 working days after receiving your orders. Delivery time maybe differs from different purchasing way or location, please kindly consult your local distributors for specific delivery time.
用途：

For Research Use Only. Not for use in diagnostic or therapeutic procedures.

引用文獻

DICAM in the Extracellular Vesicles from Astrocytes Attenuates Microglia Activation and Neuroinflammation J Han,Cells,2022

產品評價

靶點詳情

功能：

Could play a role in phagocytic activities of tissue macrophages, both in intracellular lysosomal metabolism and extracellular cell-cell and cell-pathogen interactions. Binds to tissue- and organ-specific lectins or selectins, allowing homing of macrophage subsets to particular sites. Rapid recirculation of CD68 from endosomes and lysosomes to the plasma membrane may allow macrophages to crawl over selectin-bearing substrates or other cells.
基因功能參考文獻：
1. Combined detection of tumor-associated macrophages markers, CD68 and Sema4D, in gastric carcinoma tissue shows potential to predict the trend of gastric carcinoma progression. PMID: 29434448
2. The study revealed that CD16-CD68-expressing macrophages appear to participate in ureteral neoplastic transformation. PMID: 29243545
3. A combination of CD68/CD206 density and HBV-positivity improves further predictive value for post-operative recurrence of hepatocellular carcinoma (HCC) . Quantification of CD68/CD206 macrophages and their distribution can be exploited for better postsurgical management of HCC patients. PMID: 28656201
4. Report CD68 over-expression in multinucleated giant cells and mononuclear cells in central and peripheral giant cell granuloma of jaw. PMID: 28832079
5. This study shown the CD68 expression in Microglia and Astrocytes in stroke, Alzheimer's disease, and Lewy body dementia. PMID: 28398520
6. The results of this study found that the expression levels of Cd68 and Atp5b were significantly correlated with the neurofibrillary tangle burden in the Alzheimer's Disease brain and with their cognition. PMID: 27911303
7. Taken together, these results suggested that the changes, including ox-LDL/LDL ratio, CD68(+)/RANK(+) cells number, and the levels of RANKL and HMGB1 in AS patients, favored osteoclastogenesis. PMID: 29146189
8. High expression of CD68 is associated with nonalcoholic steatohepatitis. PMID: 28951310
9. increased amount of CD68+TAM in gaps of ductal tumor structures is protective against metastatic spread in regional lymph nodes. PMID: 26391151
10. Most cases of histiocytic sarcoma expressed histiocytic markers CD68 (6 of 7 cases), CD163 (5 of 5 cases), and PU.1 (3 of 4 cases). PMID: 28805986
11. Renal expression of CD68 and the chronicity index are associated with progression to chronic kidney disease in patients with proliferative lupus nephritis. PMID: 26621103
12. Results indicate that the expression of FoxP3 was not significantly associated with survival, and suggest prognostic significance of high CD68 expression in primary central nervous system lymphoma (PCNSL). PMID: 28508176
13. Her-2 overexpression results in ICA were similar to previous reports, the finding of 28% in HGD was unexpected and may have clinical implications. Positive Her-2 DISH in 6% of LGD is novel, suggesting a role of Her-2 during BE progression PMID: 26469325
14. CD68 may play key roles in the pathogenesis of Alzheimer's disease (AD) and its complications may be via induction of inflammation; CD68 may be considered as a risk factor for development of AD and also psychotic symptoms in the patients PMID: 28465247
15. hCD68GFP/ApoE(-/-) mice provide a new approach to study macrophage accumulation in atherosclerotic plaque progression and to identify cells recruited from adoptively transferred monocytes. PMID: 27908893
16. Findings indicate that human CD68 and its mouse ortholog macrosialin located in the lysosomal membrane and share many structural similarities. PMID: 27869795
17. The strong CD68 and S100 co-expression in our case did not allow a clear-cut discrimination between the immunophenotype of histiocytic neoplasms and amelanotic melanoma, because of CD68 immunoreactivity occurring in 75% of metastatic malignant melanomas PMID: 26407839
18. Using double labeling with Iba-1 and cd68 could determine the physiological state of microglia in brain contusion based on their morphology and immunoreactivity. PMID: 27442380
19. we confirmed the similarities between epithelial ovarian cancer and fallopian tube, normal and adenocarcinoma using FOLR1, FOLR2, CD68 and CD11b markers PMID: 25971554
20. Data indicate the prognostic value of CD68 antigen in Hodgkin lymphoma (HL). PMID: 24766492
21. This study does not support a prognostic role of CD68 positivity in predicting survival. PMID: 25204373
22. we raised a possibility that the microlocalization of CD68(+) tumor-associated macrophages was an indispensable factor for the advance of oral squamous cell carcinoma. PMID: 25666753
23. Data indicate that the high CD68/CD3 ratio identifies a bad prognosis group among muscle-invasive urothelial carcinoma (UC). PMID: 24794251
24. The human CD68 promoter drives green fluorescent protein expression in all CD115(+) monocytes of adult blood, spleen, and bone marrow. PMID: 25030063
25. CD68 tumor-associated macrophage marker is not prognostic of clinical outcome in classical Hodgkin lymphoma. PMID: 24067108
26. The CD68-positive cells (those that have not yet developed into foam cells) present in the intima of saphenous vein grafts might serve as a very early marker of graft occlusion. PMID: 23275124
27. the distribution of CD68-positive cells during normal brain development may not reflect a supportive role of these microglia in axonogenesis of midterm human fetuses. PMID: 24459672
28. The MRC1/CD68 ratio is positively associated with adipose tissue lipogenesis and with muscle mitochondrial gene expression in humans. PMID: 23951013
29. CD68 has a role in poor recurrence-free survival of hepatocellular carcinoma, but CD163 is more related to active hepatitis PMID: 23555776
30. Multivariate analysis identified the density of CD163-positive cells as well as the ratio of CD163/CD68 expression as negative predictors for survival of epithelial ovarian cancer patients. PMID: 23289476
31. Follicular lymphoma patients with PSMB1 P11A (G allele) and low CD68 expression have significantly longer progression free survival with bortezomib-rituximab versus rituximab. PMID: 23549871
32. Rhinovirus colocalizes with CD68- and CD11b-positive macrophages following experimental infection in humans. PMID: 23727038
33. the marker CD68 might accurately predict early outcome of de novo cHL and could be used in combination with c-kit and TiA1 staining. PMID: 22667341
34. Suggest that the proteins or mRNAs expressed by the proinflammatory CD68(+)MR(-) macrophages may contribute to abdominal aortic aneurysm pathology. PMID: 23241402
35. After bed rest, CD68 expression was increased in LBW (P=0.03) but not in NBW individuals. PMID: 22968485
36. Increased CD68 expression was associated with Hodgkin lymphoma PMID: 22948049
37. CSF1R and cd68 gene expression is an independent predictor for progression-free survival of Hodgkin lymphoma patients. PMID: 22955918
38. CD163 staining is lower than CD68, with less non-specific staining of background inflammatory cells and Hodgkin cells, therefore is a better marker for Hodgkin lymphoma associated macrophages. PMID: 22289504
39. elderly subjects had twofold higher CD68 and CD206 gene expression (both P < 0.002) than young participants. In both studies, CD68(+) muscle macrophages were not associated with BMI. PMID: 22314623
40. CD68 may have a role in atherosclerotic plaque PMID: 22395501
41. Statins promote the beneficial remodeling of plaques in diseased mouse arteries through the stimulation of the CCR7 / CD68 emigration pathway in macrophages PMID: 22163030
42. CD68 and CD163 are prognostic factors for Korean patients with Hodgkin lymphoma PMID: 22044760
43. Data show that the number of TNF-alpha and CD68 positive cells in HIZ was significantly higher than that in the annulus fibrosus around HIZ and in the control. PMID: 21192298
44. Fibrolamellar carcinomas are positive for CD68. PMID: 21113139
45. Increased numbers of CD68-positive tumor macrophages indicate an adverse overall outcome in Hodgkin lymphoma. PMID: 21266828
46. Significant co-localization of CD36 receptor with cells of the macrophage lineage, such as CD68 positive cells. PMID: 20333725
47. Treatment with etanercept may be involved in vascular and cell proliferations with inhibition of the expression of CD68 and MMP-3 in synovium of rheumatoid arthritis patients. PMID: 20374310
48. CD68 was expressed in beta-cells of NOD mice by 14-17 weeks of age, when a large proportion of these cells were infiltrated with lymphocytes and monocytes. PMID: 12397372
49. CD68 expression is down-regulated in lymphoid cells by combinatorial interactions between PU.1 and IRF-4 PMID: 12676954
50. study expands the immunophenotype of granular cell tumor (S100, CD68, protein gene product 9.5, and inhibin-alpha) regardless of location and supports a neural origin PMID: 15214825
顯示更多

收起更多
亞細胞定位：

[Isoform Short]: Cell membrane; Single-pass type I membrane protein.; [Isoform Long]: Endosome membrane; Single-pass type I membrane protein. Lysosome membrane; Single-pass type I membrane protein.
蛋白家族：

LAMP family
組織特異性：

Highly expressed by blood monocytes and tissue macrophages. Also expressed in lymphocytes, fibroblasts and endothelial cells. Expressed in many tumor cell lines which could allow them to attach to selectins on vascular endothelium, facilitating their diss
數(shù)據(jù)庫鏈接：

HGNC: 1693

OMIM: 153634

KEGG: hsa:968

STRING: 9606.ENSP00000250092

UniGene: Hs.647419

Most popular with customers

YWHAB Recombinant Monoclonal Antibody

Applications: ELISA, WB, IHC, IF, FC

Species Reactivity: Human, Mouse, Rat
XRCC5 Recombinant Monoclonal Antibody

Applications: ELISA, WB, IHC, IF

Species Reactivity: Human
XPNPEP1 Recombinant Monoclonal Antibody

Applications: ELISA, IHC, FC

Species Reactivity: Human
XDH Recombinant Monoclonal Antibody

Applications: ELISA, WB, IHC

Species Reactivity: Human
WT1 Recombinant Monoclonal Antibody

Applications: ELISA, WB, IHC

Species Reactivity: Human
WFDC2 Recombinant Monoclonal Antibody

Applications: ELISA, WB, FC

Species Reactivity: Human
WDR5 Recombinant Monoclonal Antibody

Applications: ELISA, IHC, FC

Species Reactivity: Human
VIM Recombinant Monoclonal Antibody

Applications: ELISA, IHC, IF

Species Reactivity: Human